Effect of spironolactone and erythromycin solution in treatment of acne
Phase 2
Recruiting
- Conditions
- Acne.Acne
- Registration Number
- IRCT20181005041243N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Aged 18-40
Acne diagnosis by a dermatologist
Exclusion Criteria
Pregnancy or breastfeeding during the intervention
history of internal diseases, including endocrine diseases causing acne
alteration in diet and lifestyle during the study
having consumed systemic therapy for acne in the last 4 weeks
having consumed oral antibiotics in the last 3 months
having consumed topical therapy for acne in the last 2 weeks
having consumed isotretinoin, undertaken laser, and peeling in the last 6 months
Photosensitivity
severe or nodularis acne
polycystic ovary syndrome
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ??Acne severity index. Timepoint: At the beginning of the study (before the start of the intervention) and 6 and 12 weeks after the start of trial. Method of measurement: Acne severity index (ASI) formula.;Patients' satisfaction with acne recovery. Timepoint: At the beginning of the study (before the start of the intervention) and 6 and 12 weeks after the start of trial. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method